Loading…
Ensuring Patient Access to Critical Breakthrough Products Act of 2019
Legislative Progress
Introduced
December 6, 2019
Latest Action
December 9, 2019
Primary Sponsor
Suzan K. DelBeneDemocratic(WA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
63pct
3d open
vs 9,062 other HR bills in the 116th — cohort avg 39d
Ensuring Patient Access to Critical Breakthrough Products Act of 2019 This bill provides for Medicare coverage of medical devices that are approved under the Food and Drug Administration (FDA) Breakthrough Devices Program. (Under the program, manufacturers work with the FDA to expedite the review and approval of certain medical devices that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating human diseases or conditions.) The bill allows designated medical breakthrough devices to be temporarily covered under Medicare during a three-year transitional period. The Centers for Medicare & Medicaid Services (CMS) must assign payment codes for such devices within three months of FDA approval. The CMS must also establish a process to allow for continued coverage after the transitional period has expired, taking into account any additional evidence or data the CMS deems necessary. The CMS must also provide for temporary and, where appropriate, permanent Medicare coverage of breakthrough devices for which there is no existing benefit category (i.e., classification).
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (8)
Referred to the Subcommittee on Health.
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2021 · second_quarter · Medicare/Medicaid
Issues related to payment reform, ACOs and bundling Issues related to Protecting Access to Medicare Act Issues related to the regulation of, reimbursement for, and access to cancer diagnostics, imaging, and radiation therapies, including passage of H.R. 1892, Bipartisan Budget Act Issues related to Medicare coverage reform Issues related to coverage of diabetes technology Issues related to coverage of telehealth services Issues related to HR 5333 - Ensuring Access to Critical Breakthrough Products Act Issues related to Medicare Coverage for Innovative Technology Final Rule Issues related to Medicare coverage for digital health technologies
Client expense: $550,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
2021 · first_quarter · Medicare/Medicaid
Issues related to deficit reduction and Medicare Issues related to value-based health care and Medicare program integrity, including changes to the Stark laws and Anti-Kickback Statute Issues related to payment reform, ACOs and bundling Issues related to Protecting Access to Medicare Act Issues related to mdufa payment reform Issues related to the regulation of, reimbursement for, and access to cancer diagnostics, imaging, and radiation therapies, including passage of H.R. 1892, Bipartisan Budget Act Issues related to Medicare coverage reform Issues related to coverage of diabetes technology Issues related to coverage of telehealth services Issues related to HR 5333 - Ensuring Access to Critical Breakthrough Products Act Issues related to Medicare Coverage for Innovative Technology Final Rule Issues related to Medicare coverage for digital health technologies
Client expense: $540,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
2020 · fourth_quarter · Medicare/Medicaid
Issues related to Medicare policies on continuous glucose monitoring and closed loop systems. Issues related to value based health care and modernization of fraud and abuse laws. Issues related to Medicare coverage and payment for Breakthrough-designated medical devices, including H.R. 5333/S. 3914, the Ensuring Patient Access to Critical Breakthrough Products Act. Issues related to telemedicine and remote patient monitoring. Issues related to proposed Medicare Physician Fee Schedule cuts. Issues related to Medicare prior authorization policies.
Client expense: $771,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR)
2020 · fourth_quarter · Medicare/Medicaid
Issues related to Medicare coverage of breakthrough medical devices including, H.R.5333: Ensuring Patient Access to Critical Breakthrough Products Act of 2019.
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
H.R. 1781 - Payment Commission Data Act of 2019 H.R. 269 - PAHPA Reauthorization and Advancing Innovation Act of 2019 S. 97 - Affordable and Safe Prescription Drug Importation Act S. 1416 - Affordable Prescriptions For Patients Act of 2019 S. 1895 - Lower Health Care Costs Act H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act H.R. 5333 - OTC Monograph Reform Act H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201 - Families First Coronavirus Response Act S. 3548 - CARES Act H.R. 6800 - The Heroes Act H.R. 133 - Consolidated Appropriations Act, 2021 no specific bills, importation, supply chain integrity, 304b, orphan drugs, newborn screening, expanded access, priority review, transparency, drug shortages, drug pricing, insulin, international reference pricing
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2020 · fourth_quarter · Medicare/Medicaid
H.R. 5333, Ensuring Patient Access to Critical Breakthrough Products Act of 2019, as it relates to Medicare coverage. S. 3532, Prescription Digital Therapeutics to Support Recovery Act, as it relates to Medicare coverage.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Education
S. 1177 Elementary and Secondary Education Act. Perkins Career Technical Education Act Reauthorization. STEM Education. Workforce Training and Education. H.R. 5333 - Promoting Apprenticeships for Credentials and Employment (PACE) Act. S. 3084 - American Innovation and Competitiveness Act.
Client expense: $3,030,000 · Firm income: Not reported
2020 · third_quarter · Medicare/Medicaid
Issues related to Medicare policies on continuous glucose monitoring and closed loop systems. Issues related to value based health care and modernization of fraud and abuse laws. Issues related to Medicare coverage and payment for Breakthrough-designated medical devices, including H.R. 5333/S. 3914, the Ensuring Patient Access to Critical Breakthrough Products Act. Issues related to telemedicine and remote patient monitoring.
Client expense: $1,867,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
2020 · third_quarter · Health Issues
H.R. 1781 - Payment Commission Data Act of 2019 H.R. 269 - PAHPA Reauthorization and Advancing Innovation Act of 2019 S. 97 - Affordable and Safe Prescription Drug Importation Act S. 1416 - Affordable Prescriptions For Patients Act of 2019 S. 1895 - Lower Health Care Costs Act H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act H.R. 5333 - OTC Monograph Reform Act H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201 - Families First Coronavirus Response Act S. 3548 - CARES Act H.R. 6800 - The Heroes Act no specific bills, importation, supply chain integrity, 304b, orphan drugs, newborn screening, expanded access, priority review, transparency, drug shortages, drug pricing, insulin, international reference pricing
Client expense: Not reported · Firm income: $60,000
2020 · third_quarter · Medicare/Medicaid
H.R. 5333, Ensuring Patient Access to Critical Breakthrough Products Act of 2019, as it relates to Medicare coverage. S. 3532, Prescription Digital Therapeutics to Support Recovery Act, as it relates to Medicare coverage.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Education
S. 1177 Elementary and Secondary Education Act. Perkins Career Technical Education Act Reauthorization. STEM Education. Workforce Training and Education. H.R. 5333 - Promoting Apprenticeships for Credentials and Employment (PACE) Act. S. 3084 - American Innovation and Competitiveness Act. H.R. 2353 - Strengthening Career & Technical Education for the 21st Century Act. H.R.4508 - Promoting Real Opportunity, Success, and Prosperity through Education Reform (PROSPER) Act. H.R. 5701 / S. 2506 - To Establish an Aviation Maintenance Technician Workforce Development Pilot Program.
Client expense: $3,180,000 · Firm income: Not reported
2020 · second_quarter · Medicare/Medicaid
Issues related to Medicare policies on continuous glucose monitoring and artificial pancreas device systems. Issues related to value based health care and modernization of fraud and abuse laws. Issues related to Medicare coverage and payment for Breakthrough-designated medical devices, including H.R. 5333/S. 3914, the Ensuring Patient Access to Critical Breakthrough Products Act. Issues related to telemedicine and remote patient monitoring.
Client expense: $1,019,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Transportation, Dept of (DOT), U.S. Trade Representative (USTR)
2020 · second_quarter · Health Issues
H.R. 1781 - Payment Commission Data Act of 2019 H.R. 269 - PAHPA Reauthorization and Advancing Innovation Act of 2019 S. 97 - Affordable and Safe Prescription Drug Importation Act S. 1416 - Affordable Prescriptions For Patients Act of 2019 S. 1895 - Lower Health Care Costs Act H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act H.R. 5333 - OTC Monograph Reform Act H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201 - Families First Coronavirus Response Act S. 3548 - CARES Act H.R. 6800 - The Heroes Act no specific bills, importation, supply chain integrity, 304b, orphan drugs, newborn screening, expanded access, priority review, transparency, drug shortages, drug pricing, insulin, international reference pricing
Client expense: Not reported · Firm income: $60,000
2020 · second_quarter · Medicare/Medicaid
H.R. 5333, Ensuring Patient Access to Critical Breakthrough Products Act of 2019, as it relates to Medicare coverage. S. 3532, Prescription Digital Therapeutics to Support Recovery Act, as it relates to Medicare coverage.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Medicare/Medicaid
H.R.5333: Ensuring Patient Access to Critical Breakthrough Products Act of 2019.
Client expense: Not reported · Firm income: $40,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2020 · first_quarter · Health Issues
The Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), all provisions related to relief funding, telehealth, and Medicare in response to the novel, COVID-19 pandemic. The Families First Coronavirus Response Act (H.R. 6201), all provisions related to relief funding, Medicaid, and paid leave in response to the novel, COVID-19 pandemic. The Coronavirus Aid, Relief, and Economic Security (CARES) Act (H.R. 748), all provisions related to relief funding in response to the novel, COVID-19 pandemic. The Special Registration for Telemedicine Clarification Act (H.R. 5483 (115)), all provisions related to establishing a special registration process with the Drug Enforcement Agency (DEA) for certain providers that wish to prescribe controlled substances via telemedicine. Mainstreaming Addiction Treatment Act (S. 2074/H.R. 2482), all provisions related to removing the waiver requirement for health care providers to prescribe buprenorphine for opioid use disorder. National Suicide Hotline Designation Act of 2019 (H.R. 4194), all provisions related to requiring the Federal Communications Commission designate 9-8-8 as a universal national suicide prevention and mental health crisis hotline number. Improving Access to Remote Behavioral Health Treatment Act of 2019 (S. 2244/H.R. 4131), all provisions related to amending regulations for the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 and allowing community mental health centers to register to practice telemedicine. Comprehensive Addiction Resources Emergency Act of 2019 (S. 1365/H.R. 2569), all provisions related to providing emergency assistance to areas affected by the opioid epidemic, as well as grant funding for substance use disorder treatment research. Medication Access and Training Expansion Act of 2019 (H.R. 4974), all provisions related to prescriber training on treating patients with opioid and other substance use disorders. Resilience Investment, Support and Expansion from Trauma Act (S. 1770/H.R. 3180), all provisions related to supporting children and families who experience trauma. CREATE Opportunities Act (S. 1983/H.R. 3496), all provisions related to providing medication-assisted treatment to individuals with opioid use disorder and are incarcerated. Primary and Behavioral Health Care Access Act (H.R. 5575), all provisions related to requiring group health plans and health insurance issuers to provide for primary and behavioral health care visits without cost-sharing. Ensuring Patient Access to Critical Breakthrough Products Act of 2019 (H.R. 5333), all provisions related to ensuring prompt coverage of breakthrough devices under the Medicare program.
2020 · first_quarter · Medicare/Medicaid
Issues related to Medicare policies on continuous glucose monitoring and artificial pancreas device systems. Issues related to value based health care and modernization of fraud and abuse laws. The Patient Affordability Value and Efficiency Act; issues pertaining to protections for value-based arrangements. Issues related to Medicare coverage and payment for Breakthrough-designated medical devices, including H.R. 5333, the Ensuring Patient Access to Critical Breakthrough Products Act. Issues related to medical device, non-oral opioid pain treatment alternatives, including implementation of the SUPPORT Act (P.L. 115-271) and H.R. 5172, the Non-Opioids Prevent Addiction in the Nation (NOPAIN) Act.
Client expense: $1,346,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Transportation, Dept of (DOT)
2020 · first_quarter · Education
S. 1177 Elementary and Secondary Education Act. Perkins Career Technical Education Act Reauthorization. STEM Education. Workforce Training and Education. H.R. 5333 - Promoting Apprenticeships for Credentials and Employment (PACE) Act. S. 3084 - American Innovation and Competitiveness Act. H.R. 2353 - Strengthening Career & Technical Education for the 21st Century Act. H.R.4508 - Promoting Real Opportunity, Success, and Prosperity through Education Reform (PROSPER) Act. H.R. 5701 / S. 2506 - To Establish an Aviation Maintenance Technician Workforce Development Pilot Program.
Client expense: $3,080,000 · Firm income: Not reported
2020 · first_quarter · Health Issues
H.R. 1781 - Payment Commission Data Act of 2019 H.R. 269 - PAHPA Reauthorization and Advancing Innovation Act of 2019 S. 97 - Affordable and Safe Prescription Drug Importation Act S. 1416 - Affordable Prescriptions For Patients Act of 2019 S. 1895 - Lower Health Care Costs Act H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act H.R. 5333 - OTC Monograph Reform Act H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201 - Families First Coronavirus Response Act S. 3548 - CARES Act no specific bills, importation, supply chain integrity, 304b, orphan drugs, newborn screening, expanded access, priority review, transparency, drug shortages, drug pricing, insulin, international reference pricing
Client expense: Not reported · Firm income: $60,000
2020 · first_quarter · Medicare/Medicaid
H.R. 5333, Ensuring Patient Access to Critical Breakthrough Products Act of 2019, as it relates to Medicare coverage. S. 3532, Prescription Digital Therapeutics to Support Recovery Act, as it relates to Medicare coverage.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Medicare/Medicaid
Inform and educate congressional offices on the importance of Pennsylvania's life sciences community to patients and the Commonwealth's economy. Strong IP/Patent protections - e.g. Stronger Patents Act, S.2082 Protecting Medicare Part D and Part B - e.g. HR19, Lower Costs, More Cures Act Increases in NIH funding Support legislation that improves public health - e.g. S1712 and HR4100, the DISARM Act Access to medical technologies - e.g. Ensuring Patient Access to Critical Breakthrough Products Act, HR5333 Protecting the safety of the drug supply chain Encourage collaborative relationships between the industry and the FDA, e.g. User Fee Agreements
Client expense: Not reported · Firm income: Not reported
2020 · first_quarter · Medical/Disease Research/Clinical Labs
Inform and educate congressional offices on the importance of Pennsylvania's life sciences community to patients and the Commonwealth's economy. Strong IP/Patent protections - e.g. Stronger Patents Act, S.2082 Protecting Medicare Part D and Part B - e.g. HR19, Lower Costs, More Cures Act Increases in NIH funding Support legislation that improves public health - e.g. S1712 and HR4100, the DISARM Act Access to medical technologies - e.g. Ensuring Patient Access to Critical Breakthrough Products Act, HR5333 Protecting the safety of the drug supply chain Encourage collaborative relationships between the industry and the FDA, e.g. User Fee Agreements
Client expense: Not reported · Firm income: Not reported
2020 · first_quarter · Pharmacy
Inform and educate congressional offices on the importance of Pennsylvania's life sciences community to patients and the Commonwealth's economy. Strong IP/Patent protections - e.g. Stronger Patents Act, S.2082 Protecting Medicare Part D and Part B - e.g. HR19, Lower Costs, More Cures Act Increases in NIH funding Support legislation that improves public health - e.g. S1712 and HR4100, the DISARM Act Access to medical technologies - e.g. Ensuring Patient Access to Critical Breakthrough Products Act, HR5333 Protecting the safety of the drug supply chain Encourage collaborative relationships between the industry and the FDA, e.g. User Fee Agreements
Client expense: Not reported · Firm income: Not reported
2020 · first_quarter · Economics/Economic Development
Inform and educate congressional offices on the importance of Pennsylvania's life sciences community to patients and the Commonwealth's economy. Strong IP/Patent protections - e.g. Stronger Patents Act, S.2082 Protecting Medicare Part D and Part B - e.g. HR19, Lower Costs, More Cures Act Increases in NIH funding Support legislation that improves public health - e.g. S1712 and HR4100, the DISARM Act Access to medical technologies - e.g. Ensuring Patient Access to Critical Breakthrough Products Act, HR5333 Protecting the safety of the drug supply chain Encourage collaborative relationships between the industry and the FDA, e.g. User Fee Agreements
Client expense: Not reported · Firm income: Not reported
2020 · first_quarter · Copyright/Patent/Trademark
Inform and educate congressional offices on the importance of Pennsylvania's life sciences community to patients and the Commonwealth's economy. Strong IP/Patent protections - e.g. Stronger Patents Act, S.2082 Protecting Medicare Part D and Part B - e.g. HR19, Lower Costs, More Cures Act Increases in NIH funding Support legislation that improves public health - e.g. S1712 and HR4100, the DISARM Act Access to medical technologies - e.g. Ensuring Patient Access to Critical Breakthrough Products Act, HR5333 Protecting the safety of the drug supply chain Encourage collaborative relationships between the industry and the FDA, e.g. User Fee Agreements
Client expense: Not reported · Firm income: Not reported
2020 · first_quarter · Health Issues
Inform and educate congressional offices on the importance of Pennsylvania's life sciences community to patients and the Commonwealth's economy. Strong IP/Patent protections - e.g. Stronger Patents Act, S.2082 Protecting Medicare Part D and Part B - e.g. HR19, Lower Costs, More Cures Act Increases in NIH funding Support legislation that improves public health - e.g. S1712 and HR4100, the DISARM Act Access to medical technologies - e.g. Ensuring Patient Access to Critical Breakthrough Products Act, HR5333 Protecting the safety of the drug supply chain Encourage collaborative relationships between the industry and the FDA, e.g. User Fee Agreements
Client expense: Not reported · Firm income: Not reported
2020 · first_quarter · Taxation/Internal Revenue Code
Inform and educate congressional offices on the importance of Pennsylvania's life sciences community to patients and the Commonwealth's economy. Strong IP/Patent protections - e.g. Stronger Patents Act, S.2082 Protecting Medicare Part D and Part B - e.g. HR19, Lower Costs, More Cures Act Increases in NIH funding Support legislation that improves public health - e.g. S1712 and HR4100, the DISARM Act Access to medical technologies - e.g. Ensuring Patient Access to Critical Breakthrough Products Act, HR5333 Protecting the safety of the drug supply chain Encourage collaborative relationships between the industry and the FDA, e.g. User Fee Agreements
Client expense: Not reported · Firm income: Not reported
2019 · fourth_quarter · Medicare/Medicaid
Issues related to Medicare policies on continuous glucose monitoring and artificial pancreas device systems. Issues related to value based health care and modernization of fraud and abuse laws. The Patient Affordability Value and Efficiency Act; issues pertaining to protections for value-based arrangements. H.R. 5333, the Ensuring Patient Access to Critical Breakthrough Products Act. Issues related to medical device, non-oral opioid pain treatment alternatives, including implementation of the SUPPORT Act (P.L. 115-271) and H.R. 5172, the Non-Opioids Prevent Addiction in the Nation (NOPAIN) Act.
Client expense: $879,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · fourth_quarter · Education
S. 1177 Elementary and Secondary Education Act. Perkins Career Technical Education Act Reauthorization. STEM Education. Workforce Training and Education. H.R. 5333 - Promoting Apprenticeships for Credentials and Employment (PACE) Act. S. 3084 - American Innovation and Competitiveness Act. H.R. 2353 - Strengthening Career & Technical Education for the 21st Century Act. H.R.4508 - Promoting Real Opportunity, Success, and Prosperity through Education Reform (PROSPER) Act. H.R. 5701 / S. 2506 - To Establish an Aviation Maintenance Technician Workforce Development Pilot Program.
Client expense: $3,400,000 · Firm income: Not reported
2019 · fourth_quarter · Health Issues
H.R. 1781 - Payment Commission Data Act of 2019 H.R. 269 - PAHPA Reauthorization and Advancing Innovation Act of 2019 S. 97 - Affordable and Safe Prescription Drug Importation Act S. 1416 - Affordable Prescriptions For Patients Act of 2019 S. 1895 - Lower Health Care Costs Act H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act H.R. 5333 - OTC Monograph Reform Act no specific bills, importation, supply chain integrity, 304b, orphan drugs, newborn screening, expanded access, priority review, transparency, drug shortages, drug pricing, insulin, international reference pricing
Client expense: Not reported · Firm income: $60,000
2019 · fourth_quarter · Medicare/Medicaid
H.R. 5333, Ensuring Patient Access to Critical Breakthrough Products Act of 2019, as it relates to Medicare coverage.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Education
S. 1177 Elementary and Secondary Education Act. Perkins Career Technical Education Act Reauthorization. STEM Education. Workforce Training and Education. H.R. 5333 - Promoting Apprenticeships for Credentials and Employment (PACE) Act. S. 3084 - American Innovation and Competitiveness Act. H.R. 2353 - Strengthening Career & Technical Education for the 21st Century Act. H.R.4508 - Promoting Real Opportunity, Success, and Prosperity through Education Reform (PROSPER) Act. H.R. 5701 / S. 2506 - To Establish an Aviation Maintenance Technician Workforce Development Pilot Program.
Client expense: $3,150,000 · Firm income: Not reported
2019 · third_quarter · Health Issues
H.R. 1781 - Payment Commission Data Act of 2019 H.R. 269 - PAHPA Reauthorization and Advancing Innovation Act of 2019 S. 97 - Affordable and Safe Prescription Drug Importation Act S. 1416 - Affordable Prescriptions For Patients Act of 2019 S. 1895 - Lower Health Care Costs Act H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act H.R. 5333 - OTC Monograph Reform Act no specific bills, importation, supply chain integrity, 304b, orphan drugs, newborn screening, expanded access, priority review, transparency, drug shortages, drug pricing, insulin, international reference pricing
Client expense: Not reported · Firm income: $60,000
2019 · second_quarter · Education
S. 1177 Elementary and Secondary Education Act. Perkins Career Technical Education Act Reauthorization. STEM Education. Workforce Training and Education. H.R. 5333 - Promoting Apprenticeships for Credentials and Employment (PACE) Act. S. 3084 - American Innovation and Competitiveness Act. H.R. 2353 - Strengthening Career & Technical Education for the 21st Century Act. H.R.4508 - Promoting Real Opportunity, Success, and Prosperity through Education Reform (PROSPER) Act. H.R. 5701 / S. 2506 - To Establish an Aviation Maintenance Technician Workforce Development Pilot Program.
Client expense: $3,930,000 · Firm income: Not reported
2019 · first_quarter · Education
S. 1177 Elementary and Secondary Education Act. Perkins Career Technical Education Act Reauthorization. STEM Education. Workforce Training and Education. H.R. 5333 - Promoting Apprenticeships for Credentials and Employment (PACE) Act. S. 3084 - American Innovation and Competitiveness Act. H.R. 2353 - Strengthening Career & Technical Education for the 21st Century Act. H.R.4508 - Promoting Real Opportunity, Success, and Prosperity through Education Reform (PROSPER) Act. H.R. 5701 / S. 2506 - To Establish an Aviation Maintenance Technician Workforce Development Pilot Program.
Client expense: $3,330,000 · Firm income: Not reported
| Republican |
| NJ |
| Roger Marshall | Republican | KS |
| Scott Perry | Republican | PA |
| Terri A. Sewell | Democratic | AL |
| Tony Cárdenas | Democratic | CA |
Government targets: Air Force, Dept of, Army, Dept of (Other), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Export-Import Bank of the United States (EXIM Bank), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Security Council (NSC), Navy, Dept of, Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
Government targets: Air Force, Dept of, Army, Dept of (Other), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Export-Import Bank of the United States (EXIM Bank), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Security Council (NSC), Navy, Dept of, Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
Client expense: $125,180 · Firm income: Not reported
Government targets: Drug Enforcement Administration (DEA), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
Government targets: Air Force, Dept of, Army, Dept of (Other), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Export-Import Bank of the United States (EXIM Bank), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Security Council (NSC), Navy, Dept of, Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
Government targets: Air Force, Dept of, Army, Dept of (Other), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Export-Import Bank of the United States (EXIM Bank), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Security Council (NSC), Navy, Dept of, Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
Government targets: Air Force, Dept of, Army, Dept of (Other), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Export-Import Bank of the United States (EXIM Bank), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Security Council (NSC), Navy, Dept of, Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
Government targets: Air Force, Dept of, Army, Dept of (Other), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Export-Import Bank of the United States (EXIM Bank), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Security Council (NSC), Navy, Dept of, Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Government targets: Air Force, Dept of, Army, Dept of (Other), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Export-Import Bank of the United States (EXIM Bank), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Security Council (NSC), Navy, Dept of, Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office